7
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Tachykinins as enhancers of prostaglandin E2-induced intraocular inflammation

, &
Pages 19-25 | Published online: 08 Jul 2009
 

Abstract

The effects of tachykinins on prostaglandin E 2 (PGE 2 )-induced intraocular inflammation were investigated. PGE 2 (0.01% or 0.1%) instillation induced iridal hyperemia and protein leakage into the aqueous humor in rabbits, but caused minimal miosis. Intravitreally injected substance P (SP) or neurokinin A (NKA), on the other hand, did not induce protein leakage into the aqueous humor in normal rabbits, but they (SP 10 µg/eye or NKA 50 µg/eye) did induce long-lasting miosis. The miotic activity of SP was about fivefold stronger than that of NKA. Intravitreally injected SP (10 µg/eye) but not NKA (50 µg/eye) increased PGE 2 concentration in the aqueous humor in normal rabbits. In addition, SP (10 µg/eye) or NKA (50 µg/eye) markedly enhanced protein leakage into the aqueous humor induced by PGE 2 instillation. Pretreatment with indomethacin partially blocked the enhancing effect of SP on protein leakage, while it did not block that of NKA. These results suggest that SP or NKA may enhance intraocular inflammation in vivo. However, the mechanisms of these effects of SP and NKA may be different. The enhancing effect of SP in eye inflammation may be partially due to an increased turnover of arachidonic acid into PGE 2 caused by activation of the enzyme cyclooxygenase.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.